查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599689

电子药局市场：依产品类型、药物类型、类型、经营模式- 2025-2030 年全球预测

ePharmacy Market by Product (Cold & Flu, Dental, Skin Care), Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs), Type, Business model - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

据预测，2023年电子药局市值为536.2亿美元，预计到2024年将达到626.5亿美元，复合年增长率为17.29%，到2030年将达到1638.4亿美元。

电子药局市场是更广泛的数位健康生态系统的一个子集，是指促进药品销售和分销的线上平台。由于网路普及率的提高和消费者对网路购物的偏好的增加，该市场正在经历显着增长。这一增长的主要驱动因素包括人口老化、慢性病的增加以及确保安全和无缝交易的技术进步。对电子药局的需求在于其能够提供便利、有竞争力的价格以及轻鬆取得药品的能力，特别是对于偏远地区或行动不便的人。 ePharmacy的应用范围很广，包括非处方药、非处方食品、膳食补充剂和个人保健产品。对于最终用途，私人消费者、医院和诊所使用电子药局进行高效采购。

主要市场统计
基准年[2023] 536.2亿美元
预测年份 [2024] 626.5亿美元
预测年份 [2030] 1638.4亿美元
复合年增长率（%） 17.29%

根据市场洞察，远端医疗服务的采用和对数位平台的信任度不断提高是推动市场成长的关键因素。机会包括进入药房基础设施欠发达的新兴市场，以及扩大产品范围以包括远端咨询，从而创造全面的医疗保健体验。此外，透过资料分析扩展个人化医疗服务显示出巨大的成长潜力。然而，市场面临监管障碍、假药风险以及安全付款解决方案需求等挑战。确保资料隐私和监管合规性可能会限制进展，但也确定了创新领域。

成熟的创新研究领域包括开发强大的认证系统来打击假药、先进的物流解决方案以提高交付效率，以及人工智慧主导的技术来增强个人化医疗平台的交付等。市场竞争趋于激烈，监管监管也趋于激烈，需要不断适应和创新以维持成长。公司应专注于形成策略联盟、加强技术基础设施和加强消费者教育，以利用电子药房环境中的快速成长机会。

市场动态：揭示快速发展的电子药局市场的关键市场洞察

供需的动态交互作用正在改变电子药局市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于医疗保健领域数位技术和电子商务的快速采用，提高了可近性和灵活性
    • 全球远距咨询的进步推动电子药局设施的采用
    • 全球患有慢性和急性疾病的老年人数量不断增加
  • 市场限制因素
    • 电子药局开发需要技术专业知识和足够的基础设施
  • 市场机会
    • 将人工智慧和区块链技术引入电子药房
    • 在电子药房中引入虚拟助理
  • 市场问题
    • 对电子药局中药品标籤不当的担忧
    • 骇客和网路钓鱼活动的出现导致病患资料隐私和安全问题

波特五力：驾驭电子药局市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解电子药局市场的外部影响

外部宏观环境因素在塑造电子药局市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解电子药局市场的竞争格局

对电子药局市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：电子药局市场供应商的绩效评估

FPNV 定位矩阵是评估电子药局市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製电子药局市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，电子药局市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医疗保健领域数位技术和电子商务的快速采用提高了可近性和灵活性
      • 远距医疗正在不断发展，电子药房设施正在世界各地引入。
      • 世界各地患有慢性和急性疾病的老年人数量正在增加。
    • 抑制因素
      • 电子药局的发展需要技术专长和适当的基础设施
    • 机会
      • 人工智慧和区块链技术在电子药房的引入
      • 在电子药房僱用虚拟助理
    • 任务
      • 对电子药局中药品标籤不当的担忧
      • 由于骇客和网路钓鱼活动的出现，与病患资料隐私和安全相关的问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章电子药局市场：副产品

  • 介绍
  • 感冒和流感
  • 牙科
  • 护肤
  • 维他命
  • 减重

第七章电子药局市场：依药物类型

  • 介绍
  • 非处方药 (OTC)
  • 联合用药

第 8 章电子药局市场：按类型

  • 介绍
  • 融合的
  • 独立的

第九章电子药局市场：依经营模式

  • 介绍
  • 直接地
  • 市场
  • 药局

第10章美洲电子药局市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太电子药局市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的电子药局市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Med-Direct Africa推出网路药局，承诺降低价格
    • 美国Start-Ups在缅甸推出网路药局平台
    • 越南网路药局Medigo 筹集了超过 200 万美元的数位医疗资金
    • Flipkart 正在洽谈收购线上药局 Pharmarama
    • 网路药局Grinta 融资 100 万美国开发技术平台
    • Tata 1mg 融资 4000 万美元，由 Tata Digital主导
    • Med-Direct Africa 在尼日利亚推出网路药局。
    • Flipkart 凭藉新的「Flipkart Health+」应用程式进入医疗领域
    • 肯亚网路药局Start-UpsMYDAWA 获得盖兹基金会 120 万美元的津贴。
    • PharmEasy 融资 3.5 亿美元，成为印度首家电子药局独角兽
  • 战略分析和建议

公司名单

  • Amazon.com, Inc.
  • Apex Healthcare Berhad
  • Apollo Pharmacies Ltd.
  • Aster Pharmacies Group LLC
  • BinSina Pharmacy
  • CareOnGo
  • Chemist Direct
  • CVS Health Corporation
  • De Online Drogist
  • DOCIB Group
  • Euro-pharmas
  • Express Scripts Holding Company by Cigna
  • Farmacia Internacional
  • HealthPlus Pharmacy
  • Healthxchange Pharmacy UK Ltd.
  • Life Pharmacy
  • LloydsPharmacy Ltd.
  • Lekarna WPK SRO
  • Mahendra ePharmacy Pvt. Ltd.
  • mChemist Global Pvt. Ltd.
  • Medexpresspharma by Life Wind Medicare Pvt. Ltd.
  • Medicina Pharmacy
  • MonCoinSante
  • myPOS Software Solutions（Pvt）Ltd.
  • Netmeds by Reliance Retail Ltd.
  • Newpharma by Colruyt Group
  • OneHealth Nigeria
  • OptumRx, Inc.
  • Oxford e-Pharmacy
  • Parafarmacia-online
  • Pharm24.gr
  • Pharmacynet
  • Pharmeasy by Axelia Solutions Pvt. Ltd.
  • Practo Technologies Pvt. Ltd.
  • Rowlands Pharmacy by Phoenix Group
  • Shop Apotheke Europe NV
  • Tata 1mg
  • The French Pharmacy
  • The Independent Pharmacy
  • The Kroger Co.
  • UK Meds Direct Ltd.
  • Vamida sro
  • Walgreen Co.
  • Walmart Inc.
  • Wockhardtepharmacy
  • Zur Rose Group AG
Product Code: MRR-8C74ADFBFAFB

The ePharmacy Market was valued at USD 53.62 billion in 2023, expected to reach USD 62.65 billion in 2024, and is projected to grow at a CAGR of 17.29%, to USD 163.84 billion by 2030.

The ePharmacy market, a subset of the broader digital health ecosystem, refers to online platforms that facilitate the sale and distribution of pharmaceutical products. This market has witnessed significant growth due to the rising penetration of the internet and increasing consumer preference for online shopping. Key drivers of this growth include the expanding aging population, a rise in chronic diseases, and technological advancements that ensure secure and seamless transactions. ePharmacy's necessity lies in its ability to offer convenience, competitive pricing, and accessibility to medications, especially for those in remote locations or with mobility issues. Its application is broad, encompassing prescription medications, over-the-counter drugs, health supplements, and personal care products. In terms of end-use, individual consumers, hospitals, and clinics utilize ePharmacies for efficient procurement.

KEY MARKET STATISTICS
Base Year [2023] USD 53.62 billion
Estimated Year [2024] USD 62.65 billion
Forecast Year [2030] USD 163.84 billion
CAGR (%) 17.29%

Market insights reveal that the adoption of telehealth services and a growing trust in digital platforms are critical factors enhancing market growth. Opportunities include tapping into emerging markets with underdeveloped pharmacy infrastructure and expanding product offerings to include teleconsultations, thereby creating an integrated healthcare experience. Additionally, the expansion of personalized medicine services through data analytics presents substantial growth potential. However, the market faces challenges, such as regulatory hurdles, risks of counterfeit drugs, and the need for secure payment solutions. Ensuring data privacy and regulatory compliance can limit progress but also provide areas for innovation.

Research areas ripe for innovation include the development of robust authentication systems to combat counterfeit drugs, advanced logistics solutions for more efficient delivery, and AI-driven platforms that can enhance personalized medicine offerings. The market tends to be highly competitive with significant regulatory oversight, necessitating continuous adaptation and innovation to maintain growth. Businesses should focus on forming strategic alliances, strengthening their tech infrastructure, and enhancing consumer education to capitalize on burgeoning opportunities within the ePharmacy landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving ePharmacy Market

The ePharmacy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapid adoption of digital technologies and eCommerce in healthcare sector for better accessibility and flexibility
    • Evolution of teleconsultation across the globe leads the adoption of ePharmacy facilities
    • Growing geriatric population with chronic and acute conditions across the globe
  • Market Restraints
    • Requirement of technical expertise and adequate infrastructure for ePharmacy development
  • Market Opportunities
    • Deployment of artificial intelligence and blockchain technology in ePharmacy
    • Introduction of virtual assistance in ePharmacy
  • Market Challenges
    • Concern regarding inappropriate labeling of drugs in ePharmacy
    • Issues pertaining to patient's data privacy and security due to emergence of hacking and fishing activities

Porter's Five Forces: A Strategic Tool for Navigating the ePharmacy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the ePharmacy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the ePharmacy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the ePharmacy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the ePharmacy Market

A detailed market share analysis in the ePharmacy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the ePharmacy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the ePharmacy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the ePharmacy Market

A strategic analysis of the ePharmacy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the ePharmacy Market, highlighting leading vendors and their innovative profiles. These include Amazon.com, Inc., Apex Healthcare Berhad, Apollo Pharmacies Ltd., Aster Pharmacies Group LLC, BinSina Pharmacy, CareOnGo, Chemist Direct, CVS Health Corporation, De Online Drogist, DOCIB Group, Euro-pharmas, Express Scripts Holding Company by Cigna, Farmacia Internacional, HealthPlus Pharmacy, Healthxchange Pharmacy UK Ltd., Life Pharmacy, LloydsPharmacy Ltd., Lekarna WPK SRO, Mahendra ePharmacy Pvt. Ltd., mChemist Global Pvt. Ltd., Medexpresspharma by Life Wind Medicare Pvt. Ltd., Medicina Pharmacy, MonCoinSante, myPOS Software Solutions (Pvt) Ltd., Netmeds by Reliance Retail Ltd., Newpharma by Colruyt Group, OneHealth Nigeria, OptumRx, Inc., Oxford e-Pharmacy, Parafarmacia-online, Pharm24.gr, Pharmacynet, Pharmeasy by Axelia Solutions Pvt. Ltd., Practo Technologies Pvt. Ltd., Rowlands Pharmacy by Phoenix Group, Shop Apotheke Europe N.V., Tata 1mg, The French Pharmacy, The Independent Pharmacy, The Kroger Co., UK Meds Direct Ltd., Vamida s.r.o., Walgreen Co., Walmart Inc., Wockhardtepharmacy, and Zur Rose Group AG.

Market Segmentation & Coverage

This research report categorizes the ePharmacy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cold & Flu, Dental, Skin Care, Vitamins, and Weight Loss.
  • Based on Drug Type, market is studied across Over the Counter (OTC) Drugs and Prescription Drugs.
  • Based on Type, market is studied across Integrated and Standalone.
  • Based on Business model, market is studied across Direct, Marketplace, and Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid adoption of digital technologies and eCommerce in healthcare sector for better accessibility and flexibility
      • 5.1.1.2. Evolution of teleconsultation across the globe leads the adoption of ePharmacy facilities
      • 5.1.1.3. Growing geriatric population with chronic and acute conditions across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of technical expertise and adequate infrastructure for ePharmacy development
    • 5.1.3. Opportunities
      • 5.1.3.1. Deployment of artificial intelligence and blockchain technology in ePharmacy
      • 5.1.3.2. Introduction of virtual assistance in ePharmacy
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding inappropriate labeling of drugs in ePharmacy
      • 5.1.4.2. Issues pertaining to patient's data privacy and security due to emergence of hacking and fishing activities
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. ePharmacy Market, by Product

  • 6.1. Introduction
  • 6.2. Cold & Flu
  • 6.3. Dental
  • 6.4. Skin Care
  • 6.5. Vitamins
  • 6.6. Weight Loss

7. ePharmacy Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Over the Counter (OTC) Drugs
  • 7.3. Prescription Drugs

8. ePharmacy Market, by Type

  • 8.1. Introduction
  • 8.2. Integrated
  • 8.3. Standalone

9. ePharmacy Market, by Business model

  • 9.1. Introduction
  • 9.2. Direct
  • 9.3. Marketplace
  • 9.4. Pharmacy

10. Americas ePharmacy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific ePharmacy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa ePharmacy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Med-Direct Africa Launches e-Pharmacy, Promises Price Reduction.
    • 13.3.2. US startup launches e-pharmacy platform in Myanmar.
    • 13.3.3. Vietnamese e-pharmacy Medigo raises $2M and more digital health fundings.
    • 13.3.4. Flipkart In Discussions To Acquire Online Pharmacy Pharmallama
    • 13.3.5. e-pharmacy Grinta raises US$8 mln to develop its tech platform.
    • 13.3.6. Tata 1mg raises $40 mn led by Tata Digital, becomes unicorn.
    • 13.3.7. Med-Direct Africa launches e-Pharmacy in Nigeria.
    • 13.3.8. Flipkart taps healthcare sector with brand new 'Flipkart Health+' app.
    • 13.3.9. Kenyan e-pharmacy startup MYDAWA banks $1.2m grant funding from Gates.
    • 13.3.10. PharmEasy Raises $350 Mn; Becomes India's First Epharmacy Unicorn.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amazon.com, Inc.
  • 2. Apex Healthcare Berhad
  • 3. Apollo Pharmacies Ltd.
  • 4. Aster Pharmacies Group LLC
  • 5. BinSina Pharmacy
  • 6. CareOnGo
  • 7. Chemist Direct
  • 8. CVS Health Corporation
  • 9. De Online Drogist
  • 10. DOCIB Group
  • 11. Euro-pharmas
  • 12. Express Scripts Holding Company by Cigna
  • 13. Farmacia Internacional
  • 14. HealthPlus Pharmacy
  • 15. Healthxchange Pharmacy UK Ltd.
  • 16. Life Pharmacy
  • 17. LloydsPharmacy Ltd.
  • 18. Lekarna WPK SRO
  • 19. Mahendra ePharmacy Pvt. Ltd.
  • 20. mChemist Global Pvt. Ltd.
  • 21. Medexpresspharma by Life Wind Medicare Pvt. Ltd.
  • 22. Medicina Pharmacy
  • 23. MonCoinSante
  • 24. myPOS Software Solutions (Pvt) Ltd.
  • 25. Netmeds by Reliance Retail Ltd.
  • 26. Newpharma by Colruyt Group
  • 27. OneHealth Nigeria
  • 28. OptumRx, Inc.
  • 29. Oxford e-Pharmacy
  • 30. Parafarmacia-online
  • 31. Pharm24.gr
  • 32. Pharmacynet
  • 33. Pharmeasy by Axelia Solutions Pvt. Ltd.
  • 34. Practo Technologies Pvt. Ltd.
  • 35. Rowlands Pharmacy by Phoenix Group
  • 36. Shop Apotheke Europe N.V.
  • 37. Tata 1mg
  • 38. The French Pharmacy
  • 39. The Independent Pharmacy
  • 40. The Kroger Co.
  • 41. UK Meds Direct Ltd.
  • 42. Vamida s.r.o.
  • 43. Walgreen Co.
  • 44. Walmart Inc.
  • 45. Wockhardtepharmacy
  • 46. Zur Rose Group AG

LIST OF FIGURES

  • FIGURE 1. EPHARMACY MARKET RESEARCH PROCESS
  • FIGURE 2. EPHARMACY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPHARMACY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPHARMACY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPHARMACY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPHARMACY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPHARMACY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPHARMACY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPHARMACY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPHARMACY MARKET DYNAMICS
  • TABLE 7. GLOBAL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPHARMACY MARKET SIZE, BY COLD & FLU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPHARMACY MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPHARMACY MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPHARMACY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPHARMACY MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPHARMACY MARKET SIZE, BY OVER THE COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPHARMACY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPHARMACY MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPHARMACY MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPHARMACY MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPHARMACY MARKET SIZE, BY MARKETPLACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPHARMACY MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 191. EPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. EPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023